Skip to main content
AbbVie Inc. logo

AbbVie Inc. — Investor Relations & Filings

Ticker · ABBV ISIN · US00287Y1091 LEI · FR5LCKFTG8054YNNRU85 US Manufacturing
Filings indexed 1,569 across all filing types
Latest filing 2026-01-05 Director's Dealing
Country US United States of America
Listing US ABBV

About AbbVie Inc.

https://www.abbvie.com/

AbbVie Inc. is a global, research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapeutic solutions. The company's mission is to address complex health issues and make a significant impact on patients' lives by combining advanced science with deep expertise. AbbVie develops treatments across various therapeutic areas, aiming to solve serious health challenges. In addition to its proprietary product pipeline, the company also offers contract manufacturing services for both small molecules and biologics, supporting other pharmaceutical partners in their development and production needs.

Recent filings

Filing Released Lang Actions
Director's Dealing 2026
Director's Dealing
2026-01-05 English
Director's Dealing 2026
Director's Dealing
2026-01-05 English
Director's Dealing 2026
Director's Dealing
2026-01-05 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-04 English
8-K
Regulatory Filings
2025-10-31 English
8-K
Regulatory Filings
2025-10-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.